Cervical cancer control in Latin America: A call to action

Cervical cancer (CC) is second most common cause of cancer in Latin America and is a leading cause of cancer mortality among women. In 2015, an estimated 74,488 women will be diagnosed with CC in Latin America and 31,303 will die of the disease. CC mortality is projected to increase by 45% by 2030 d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer 2016-02, Vol.122 (4), p.502-514
Hauptverfasser: Bychkovsky, Brittany L., Ferreyra, Mayra E., Strasser‐Weippl, Kathrin, Herold, Christina I., de Lima Lopes, Gilberto, Dizon, Don S., Schmeler, Kathleen M., Del Carmen, Marcela, Randall, Tom C., Nogueira‐Rodrigues, Angelica, de Carvalho Calabrich, Aknar Freire, St. Louis, Jessica, Vail, Caroline M., Goss, Paul E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Cervical cancer (CC) is second most common cause of cancer in Latin America and is a leading cause of cancer mortality among women. In 2015, an estimated 74,488 women will be diagnosed with CC in Latin America and 31,303 will die of the disease. CC mortality is projected to increase by 45% by 2030 despite human papillomavirus (HPV) vaccination and screening efforts. In this setting, the goal was of the current study was to examine CC control efforts in Latin America and identify deficiencies in these efforts that could be addressed to reduce CC incidence and mortality. The authors found that HPV vaccination has been introduced in the majority of Latin American countries, and there is now a need to monitor the success (or shortcomings) of these programs and to ensure that these programs are sustainable. This topic was also reviewed in light of emerging data demonstrating that visual inspection with acetic acid and HPV DNA testing without Papanicolaou tests have efficacy from a screening perspective and are good alternatives to cytology‐based screening programs. Overall, there is a need to build capacity for CC control in Latin America and the best strategy will depend on the country/region and must be tailored to meet the needs of the population as well as available resources. Cancer 2016;122:502–514. © 2015 American Cancer Society. This review of cervical cancer control in Latin America found that, despite screening and vaccination efforts, cervical cancer incidence and mortality are rising in the region. In this setting, Latin American countries need to reassess their cervical cancer prevention efforts and increase their capacity to screen and vaccinate women at risk of human papillomavirus infection and cervical cancer.
ISSN:0008-543X
1097-0142
DOI:10.1002/cncr.29813